|
Volumn 38, Issue 4, 1995, Pages 670-674
|
Safety of intravenous valproate
a b c d e f g |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
VALPROATE SEMISODIUM;
VALPROIC ACID;
ADOLESCENT;
ADULT;
AGED;
ANTICONVULSANT THERAPY;
ARTICLE;
CHILD;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INFUSION;
DRUG SAFETY;
EPILEPSY;
GASTROINTESTINAL TOXICITY;
HUMAN;
INJECTION SITE;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEUROTOXICITY;
PAIN;
PRIORITY JOURNAL;
SEIZURE;
TASTE DISORDER;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CHILD;
CHILD, PRESCHOOL;
EPILEPSY;
HOSPITALIZATION;
HUMAN;
INFUSIONS, INTRAVENOUS;
MIDDLE AGE;
SAFETY;
VALPROIC ACID;
|
EID: 0029093827
PISSN: 03645134
EISSN: 15318249
Source Type: Journal
DOI: 10.1002/ana.410380418 Document Type: Article |
Times cited : (75)
|
References (12)
|